Table 1.
The demographic and clinical information of subjects.
| No. | Age | Sex | REUa scoring | Sequencing | E. coli isolation | ||
|---|---|---|---|---|---|---|---|
| REU | Score | Mucosa | Tissue | ||||
| OLP1 | 67 | F | R5E3 | 9.5 | Gb | G | NDd |
| OLP2 | 68 | F | R2E2 | 5 | G | G | ND |
| OLP4-1st | 55 | F | R2E4 | 8 | G | G | ND |
| OLP4-2nd | 57 | F | R5E2 | 8 | Mc | M | ND |
| OLP5 | 74 | M | R2E1 | 3.5 | ND | ND | K12-5.1 |
| OLP6 | 61 | F | R7E5 | 14.5 | ND | G | ND |
| OLP7 | 60 | F | R1E3U1 | 7.5 | ND | ND | K12-7.1 |
| K12-7.2 | |||||||
| K12-7.3 | |||||||
| OLP8 | 52 | F | R2E5 | 9.5 | ND | G | ND |
| OLP9 | 76 | M | R3E4U1 | 11 | M | M | ND |
| OLP10 | 54 | M | R6E6U1 | 17 | M | M | ND |
| OLP11 | 59 | M | R5E5 | 12.5 | M | M | ND |
aR, reticulation; E, erythema; U, ulceration, bG, Roche 454 GS FLX Titanium System; cM, Illumina MiSeq System; dND, not done.